Primary Sclerosing Cholangitis

Tags

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis

Study title	A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Disease or condition	Primary Sclerosing Cholangitis
Study type	Interventional (clinical trial)
Intervention/treatment	Volixibat (capsule)
Phase	2
Study site	Duke University
Study location	Durham, NC
Principal investigator	Julius Wilder
Study coordinator name and email	Adele Gaskin; adele.gaskin@duke.edu
Phone Contact	919-684-0742
Clinicaltrials.gov link	https://clinicaltrials.gov/ct2/show/NCT04663308